# Triumvira Immunologics funding: rounds and investors

> Triumvira Immunologics has raised $45M across 1 round since 2022. Investors include B Capital and Northpond Ventures. Every round with its source.

Source: https://millionrounds.com/company/triumvira-immunologics (Millionrounds; every figure on the page links to its filing or article)

United States · [Series A startup](https://millionrounds.com/companies)

# Who invested in *Triumvira Immunologics*

One round we have observed, with the 2 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Funding summary Updated 26 Oct 2026

**$45M** raised across 1 round since 2022, from 1 source

- **Latest round:** Series A, $45M Mar 2022
- **Investors:** 2

See who backed them

## The rounds

- **Mar 2022** Series A **$45M** [B Capital](https://millionrounds.com/fund/b-capital) [Northpond Ventures](https://millionrounds.com/fund/northpond-ventures) Source recorded SEC filing: $36M sold, first sale Apr 2021

## Everyone who backed them

[B Capital](https://millionrounds.com/fund/b-capital) VC firm **1** round

[Northpond Ventures](https://millionrounds.com/fund/northpond-ventures) Private equity **1** round

Missing a round, or an investor who was in one? [Tell us](https://millionrounds.com/corrections?slug=triumvira-immunologics).

## Also claim to have backed them

This firm lists Triumvira Immunologics as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.

[Myeloma Investment Fund](https://millionrounds.com/fund/myeloma-investment-fund) Corporate VC Per its own site

## Quick answers about Triumvira Immunologics

### Who invested in Triumvira Immunologics?

Triumvira Immunologics's investors include B Capital and Northpond Ventures.

### How much has Triumvira Immunologics raised?

Triumvira Immunologics has raised $45M across 1 round since 2022.

### When did Triumvira Immunologics last raise?

Triumvira Immunologics's most recent round was a Series A of $45M in Mar 2022.

### What was Triumvira Immunologics's biggest round?

Its most recent round, $45M in Mar 2022, is also its largest on record.

### Who backed Triumvira Immunologics first?

Triumvira Immunologics's first round on record, in Mar 2022, was backed by B Capital and Northpond Ventures.

### What stage is Triumvira Immunologics at?

Triumvira Immunologics's latest named round is a Series A, in Mar 2022.

### Where is Triumvira Immunologics based?

Triumvira Immunologics is based in the United States.

## Companies like Triumvira Immunologics

In the same sector, and raised in the last eighteen months.

[**Star Therapeutics** $325M · Oct 2026](https://millionrounds.com/company/star-therapeutics)[**Promaxo** $106M · Oct 2026](https://millionrounds.com/company/promaxo)[**Prolific Machines** $105M · Oct 2026](https://millionrounds.com/company/prolific-machines)[**IMIO** $19M · Oct 2026](https://millionrounds.com/company/imio)[**Clinical Ink** $24M · Oct 2026](https://millionrounds.com/company/clinical-ink)[**Rejuvenate Bio** $13M · Oct 2026](https://millionrounds.com/company/rejuvenate-bio)

## Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.

Open the investor searchOr these rounds in the app